MedPath

Role of PET/MRI in Head and Neck Cancer

Completed
Conditions
Head and Neck Cancer
Benign Neoplasm
Malignant Neoplasm
Interventions
Radiation: Radiotherapy
Registration Number
NCT04360993
Lead Sponsor
University of Pecs
Brief Summary

Study aim was to investigate the diagnostic role of Positron Emission Tomography / Magnetic Resonance Imaging (PET/MRI) in head and neck cancer.

Detailed Description

This study was assessed the role of Diffusion weighted imaging (DWI) in discriminating between benign and malignant lesions in Head and neck cancer as well as studying the relationship between glucose metabolism (18F-FDG) and Apparent diffusion coefficient (ADC) for better tumor assessment.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
110
Inclusion Criteria
  • Proved Head and neck cancer
  • Underwent PET/CT and PET/MRI
  • Lymph nodes due to primary Head and neck cancer.

For healthy subject:

  • No previous history of malignancy.
  • no inflammation or infection in the neck region.
  • lymph node size <10mm.
Read More
Exclusion Criteria
  • patients treated before by radiotherapy / chemoradiotherapy
  • patients underwent surgery
  • artifacts
Read More

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Patients underwent PET/CT & PET/MRIRadiotherapyPatients with head and neck cancer were underwent PET/CT and PET/MRI for staging, assessment and follow up
Primary Outcome Measures
NameTimeMethod
Difference in Apparent diffusion coefficient value between benign and malignant lesionsBaseline

Apparent diffusion coefficient (ADC) was measured from benign and malignant lymph nodes by drawing region of interest (ROI) on the most homogeneous and most solid part in the target lymph node. Higher ADC value in Benign lymph node means that there are more water molecules movement inside the lymph node, more water molecules movement resulting in higher Apparent diffusion coefficient value. in malignant nodes and due to more tumor tissue, the result is to have lower water molecules motion so, lower ADC value.

Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath